DMK Pharmaceuticals Statistics
Total Valuation
DMKPQ has a market cap or net worth of $251,538. The enterprise value is -$6.35 million.
| Market Cap | 251,538 |
| Enterprise Value | -6.35M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
DMKPQ has 7.07 million shares outstanding. The number of shares has increased by 229.77% in one year.
| Shares Outstanding | 7.07M |
| Shares Change (YoY) | +229.77% |
| Shares Change (QoQ) | +174.99% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.59
| Current Ratio | 0.59 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 64.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -263.80% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $329,063 |
| Profits Per Employee | -$2.02M |
| Employee Count | 11 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 5.66 |
Taxes
In the past 12 months, DMKPQ has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.43% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -99.43% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 35.60 |
| Average Volume (30 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DMKPQ had revenue of $3.62 million and -$22.23 million in losses. Loss per share was -$9.90.
| Revenue | 3.62M |
| Gross Profit | -1.35M |
| Operating Income | -25.34M |
| Pretax Income | -22.23M |
| Net Income | -22.23M |
| EBITDA | -21.94M |
| EBIT | -22.58M |
| Loss Per Share | -$9.90 |
Balance Sheet
The company has $6.66 million in cash and $63,209 in debt, giving a net cash position of $6.60 million or $0.93 per share.
| Cash & Cash Equivalents | 6.66M |
| Total Debt | 63,209 |
| Net Cash | 6.60M |
| Net Cash Per Share | $0.93 |
| Equity / Book Value | -5.29M |
| Book Value Per Share | -0.75 |
| Working Capital | -5.59M |
Cash Flow
In the last 12 months, operating cash flow was -$9.38 million and capital expenditures -$91,494, giving a free cash flow of -$9.47 million.
| Operating Cash Flow | -9.38M |
| Capital Expenditures | -91,494 |
| Free Cash Flow | -9.47M |
| FCF Per Share | -$1.34 |
Margins
Gross margin is -37.30%, with operating and profit margins of -700.02% and -614.21%.
| Gross Margin | -37.30% |
| Operating Margin | -700.02% |
| Pretax Margin | -614.16% |
| Profit Margin | -614.21% |
| EBITDA Margin | -606.19% |
| EBIT Margin | -623.76% |
| FCF Margin | -261.54% |
Dividends & Yields
DMKPQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -229.77% |
| Shareholder Yield | -229.77% |
| Earnings Yield | -8,838.67% |
| FCF Yield | -3,763.59% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DMKPQ has an Altman Z-Score of -59.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -59.21 |
| Piotroski F-Score | 3 |